Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone

By WebmasterDecember 22, 2014November 1st, 2024No Comments

Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone
Read more here

Previous PostQR Pharma Announces the Appointment of New Chairman and New Board Member
Next PostOssianix Expands and Extends its Research Collaboration with Lundbeck on CNS Therapeutics